Benzinga's Top Pre-Market Gainers

Endocyte Inc

soared 109.74% to $7.97 in the pre-market trading. Merck

and Endocyte have entered into an exclusive worldwide agreement to develop and commercialize Phase III cancer candidate vintafolide. Dreams Inc (NYSE Amex: DRJ) moved up 23.46% to $3.21 in the pre-market session. Fanatics announced its plans to acquire DRJ for $3.45 per share in cash. First Solar Inc

surged 5.04% to $21.88 in the pre-market session. FSLR's PEG ratio is 1.02. Advanced Micro Devices Inc

added 2.20% to $7.90 in the pre-market session. AMD is scheduled to report its quarterly earnings on April 19.